Tim Sandle, PhD

Automated Microbial Identification: A Comparison of USP and EP Approaches

Friday, July 05, 2013

Implications of the Human Microbiome on Pharmaceutical Microbiology

Wednesday, August 28, 2013

A Comparative Study of Different Methods for Endotoxin Destruction

Monday, October 28, 2013

Pharmaceutical Product Impurities: Considering Beta Glucans

Saturday, August 31, 2013

Assessment of Culture Media in Pharmaceutical Microbiology

Wednesday, June 18, 2014

Variability and Test Error with the LAL Assay

Thursday, August 28, 2014

The Risk of Bacillus cereus to Pharmaceutical Manufacturing

Friday, November 28, 2014

Current Methods and Approaches for Viral Clearance

Wednesday, September 30, 2015

Pharmaceutical Facility Sanitization: Best Practices Considered

Thursday, March 31, 2016

Key Criteria for the Selection of Rapid and Alternative Microbiological Methods

Saturday, April 30, 2016

Removal of Endotoxin from Protein in Pharmaceutical Processes

Friday, July 29, 2016

Establishing a Contamination Control Strategy for Aseptic Processing

Thursday, March 16, 2017

The Problem of Biofilms and Pharmaceutical Water Systems

Friday, December 22, 2017

Applying Data Integrity Principles to the Cleanroom

Thursday, March 21, 2019

Focusing on the Operator: Reducing Facility Environmental Contamination

Tuesday, April 23, 2019

Multidrug Antimicrobial Resistance Testing and Fecal Transplant Therapy Risks

Friday, October 11, 2019

Endotoxin Testing as a Detection Method for Bacterial Biofilms

Friday, November 08, 2019

Minimizing Microbial Survival of Cleanroom Surfaces

Tuesday, March 24, 2020

Effectivity of HEPA Filters to Remove Viruses from Air Entering Cleanrooms

Monday, June 22, 2020

Historical Milestones and Industry Drivers in the Development of Recombinant Lysate for Bacterial Endotoxin Testing

Monday, October 05, 2020

Articles by Tim Sandle, PhD